Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue
Authors:
- Sylvain ManfrediSMSylvain Manfredi
- Mael PagenaultMPMael Pagenault
- Anne-Sophie de Lajarte-ThirouardALAnne-Sophie de Lajarte-Thirouard
- Jean-François BretagneJBJean-François Bretagne
- 1 November 2007
- journal article
- case report
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 19 (11) , 1021-1025
Abstract
Little is known about the long-term results of treating gastric carcinoid tumors with a slow-release somatostatin analogue. We report three patients with type 1 and 2 gastric carcinoid tumors who were treated in the above mentioned way and followed for 27-50 months. In all cases, alternative endoscopic or surgical management was considered but deemed inappropriate. Treatment with a slow-release somatostatin analogue was begun in light of a favorable recent report. The result was regression or complete disappearance of macroscopic fundal tumors. No side-effects were reported and, most notably, none of the patients developed gallstones. This small study may help define the optimal duration, dose, and administration interval of the treatment. Slow-release somatostatin analogue is a safe and efficacious treatment for type 1 and 2 gastric carcinoid tumors, and can be used when tumors are growing rapidly. Slow-release somatostatin analogue represents an alternative to repeated endoscopic treatment or high-risk surgery.Keywords
This publication has 21 references indexed in Scilit:
- Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatmentSurgery, 2004
- Gastric carcinoids in patients with hypergastrinemiaJournal of the American College of Surgeons, 2004
- Regression of Type II Gastric Carcinoids in Multiple Endocrine Neoplasia Type 1 Patients with Zollinger‐Ellison Syndrome after Surgical Excision of All GastrinomasWorld Journal of Surgery, 2004
- A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?American Journal of Gastroenterology, 2004
- Treatment of Type II Gastric Carcinoid Tumors with Somatostatin AnaloguesNew England Journal of Medicine, 2000
- The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoidsGastroenterology, 1997
- Clinical Manifestations of Carcinoid DiseaseWorld Journal of Surgery, 1996
- Fundic argyrophil carcinoid tumor in a patient with sporadic-type zollinger-ellison syndromeDigestive Diseases and Sciences, 1995
- Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic studyGastroenterology, 1993
- Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomyGastroenterology, 1992